MedTrace Logo

Topical Cyclosporine and Disease Progression

NCT00567983 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2008-09-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.

Conditions

  • Disease Progression
  • Disease Severity
  • Staining
  • Schirmers
  • OSDI

Interventions

DRUG

Restasis

Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily

DRUG

Endura

Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • Sanjay Rao · Lakeside Eye Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00567983 on ClinicalTrials.gov